IREN heads into the final days of September with a contradictory setup: short sellers have been reducing positions sharply over the past month, yet the borrow market remains extremely tight and the stock has still shed 15% this week alongside the broader mining sector.
The most striking feature in the lending market is not what shorts are doing now but where availability stands after a month of covering. Short interest has fallen 21% over the past 30 days to 27.7% of free float. That is a significant reduction. Yet availability remains pinched at around 10.7%, far from loose territory, after spending most of September between 1% and 8%. The borrow cost has also eased, dropping 14% on the week to 0.87%, a one-month low. Those two readings together suggest a market where shorts have covered aggressively but the lending pool has not meaningfully reopened, which keeps any residual short position in a structurally expensive neighbourhood. The ORTEX short score of 68.3 is high on an absolute basis, ranking in the 6th percentile of the universe on short score, though it has been drifting lower all week as covering continues.
Options are not adding much heat to the story. The put/call ratio is at 0.70, barely a tenth of a standard deviation below its 20-day average of 0.70. That is a neutral read, well inside the 52-week range of 0.59 to 1.08, and consistent with a market that is not actively chasing downside protection despite the week's price drop. The week's 15% decline in IREN is therefore largely a sector event rather than a positioning-driven one. Peers tell a similar story: fell 13.2%, shed 12.9%, dropped 13.7%, and led the group lower at 16.8%. IREN's move is in line with, not worse than, its closest correlated names.
The Street remains constructively positioned, though not without caveats. The analyst consensus mean price target is $77.69 against a current price of $41.38, implying roughly 88% upside. That gap is wide enough to warrant scrutiny: it reflects several recent initiations at elevated targets. Northland Capital Markets launched coverage at Outperform with a $99 target on September 18. Rothschild came in at the other end on September 21, initiating at Neutral with a $40 target, essentially at the current price. On September 29, B. Riley trimmed its Buy target from $96 to $91. The most notable move of the past two weeks was JP Morgan's upgrade on September 14, flipping from Underweight to Overweight and raising its target from $46 to $65. That is a meaningful shift from a bellwether firm, though JP Morgan's target still sits well below the bull camp. The bulls lean on IREN's renewable energy positioning and growing AI cloud services capacity, largely sold out for the next year. The bears point to the ongoing transition away from bitcoin mining, weak current profitability (EV/EBITDA has contracted sharply, PE is deeply negative), and the company's dependence on financing markets staying open.
On the factor scorecard, the picture is mixed in an instructive way. EPS momentum over 30 and 90 days ranks in the 98th to 100th percentile of the ORTEX universe, and EPS surprise ranks at the 95th. Analyst recommendation differential ranks at the 99th percentile, reflecting how far the current price sits below consensus targets. Against that, the short score ranks in the 6th percentile and availability in the 4th: the two most bearish readings in the dataset. Goldman Sachs filed a 13G in August disclosing a 9.4% stake, and Bank of America filed a 13G the same month at 5.8%. No activist 13D filings have been made, and all 13D/G holders carry the standard caveat that stakes are as-last-disclosed and a holder falling below 5% need not refile.
Retail attention is also worth a note. Wikipedia views are running 1.69 standard deviations above IREN's own 90-day baseline, the highest attention reading in the dataset, though this reflects general interest rather than any operational indicator. With earnings scheduled for November 6, the next five weeks bring the combination of sector volatility, a contested analyst picture, and a still-elevated short position that has been trimming but has not fully cleared.
What to watch is whether the pace of short covering continues as the stock stabilises after this week's sector-wide selloff, or whether lower availability reasserts itself if the stock rallies and the remaining 27.7% short position comes under pressure ahead of the November earnings date.
See the live data behind this article on ORTEX.
Open IREN on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
